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Abstract
Objective
To identify the white matter correlates of apathy and impulsivity in the major syndromes
associated with frontotemporal lobar degeneration, using diﬀusion-weighted imaging and data
from the PiPPIN (Pick’s Disease and Progressive Supranuclear Palsy: Prevalence and In-
cidence) study. We included behavioral and language variants of frontotemporal dementia,
corticobasal syndrome, and progressive supranuclear palsy.
Methods
Seventy patients and 30 controls underwent diﬀusion tensor imaging at 3-tesla after detailed
assessment of apathy and impulsivity. We used tract-based spatial statistics of fractional an-
isotropy and mean diﬀusivity, correlating with 8 orthogonal dimensions of apathy and im-
pulsivity derived from a principal component analysis of neuropsychological, behavioral, and
questionnaire measures.
Results
Three components were associated with signiﬁcant white matter tract abnormalities. Carer-
rated change in everyday skills, self-care, and motivation correlated with widespread changes in
dorsal frontoparietal and corticospinal tracts, while carer observations of impulsive–apathetic
and challenging behaviors revealed disruption in ventral frontotemporal tracts. Objective
neuropsychological tests of cognitive control, reﬂection impulsivity, and reward responsiveness
were associated with focal changes in the right frontal lobe and presupplementary motor area.
These changes were observed across clinical diagnostic groups, and were not restricted to the
disorders for which diagnostic criteria include apathy and impulsivity.
Conclusion
The current study provides evidence of distinct structural network changes in white matter
associated with diﬀerent neurobehavioral components of apathy and impulsivity across the
diverse spectrum of syndromes and pathologies associated with frontotemporal lobar
degeneration.
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Apathy and impulsivity are common and often coexistent in
neurodegenerative disorders, including the clinical syndromes
resulting from frontotemporal lobar degeneration
(FTLD).1–3 They are diﬃcult to treat and cause substantial
patient morbidity and carer distress.4 Research into the causes
and treatment of apathy and impulsivity is challenging be-
cause they are both multifaceted constructs: apathy reﬂects
abnormal goal-directed behavior, from dysfunction in cogni-
tive, emotional, and behavioral domains,5 while impulsivity is
the tendency to act prematurely, without forethought or ap-
propriate consideration of risk.6
Resolving the neurobiological basis of apathy and impulsivity
in neurodegenerative disease would facilitate the de-
velopment and assessment of eﬀective treatments and neu-
roprotective strategies. Herein, we focus on the
heterogeneous clinical syndromes associated with FTLD,
including behavioral variant frontotemporal dementia
(bvFTD), primary progressive aphasias (nonﬂuent agram-
matic variant [nvPPA], semantic variant [svPPA], and log-
openic variant PPA), progressive supranuclear palsy (PSP),
and the corticobasal syndrome (CBS).
We tested the hypothesis that across these diverse clinical
syndromes, regionally speciﬁc pathology of white matter
tracts as measured by diﬀusion tensor imaging (DTI)7,8
leads to diﬀerent proﬁles of apathetic and impulsive
behaviors.9,10 We consider the spectrum of FTLD dis-
orders, rather than each separate syndrome, for 2 reasons.
First, there is phenotypic overlap between syndromes.3,11
Second, apathy and impulsivity occur to a variable degree in
each disorder,3 even where they are not diagnostic criteria.
We predicted that separate dimensions of apathy and im-
pulsivity would be associated with degeneration of distinct
white matter tracts in neural systems supporting motiva-
tional and cognitive control.
Methods
Standard protocol approvals, registrations,
and patient consents
The study was approved by the Cambridge 2 research ethics
committee (reference 12/EE/0475) and supported by the
National Institute for Health Research clinical research net-
work (ID-15504). Informed consent was obtained at each
study visit, with the personal consultee process used for
participants who lacked mental capacity, in accordance with
UK law.
Participants
The Pick’s Disease and Progressive Supranuclear Palsy:
Prevalence and Incidence (PiPPIN) study recruited 204
participants. Recruitment and diagnostic criteria have been
published previously.11 In brief, patients met clinical di-
agnostic criteria for behavioral12 and language13 variants of
frontotemporal dementia (svPPA, nvPPA, logopenic variant
PPA, and “other PPA” [not meeting criteria for 1 of the 3
deﬁned subtypes]), CBS,14 and possible, probable, or deﬁnite
PSP15 (predominantly PSP Richardson syndrome under the
revised criteria16). Fifty healthy age- and sex-matched controls
with no signiﬁcant neurologic or psychiatric history were
recruited. Participants were tested on their usual medication:
40% took “antidepressant” medications (for aﬀective or be-
havioral indications), 29% dopaminergic medication, 4% an-
tipsychotic medication, and 37% other centrally acting
medications (benzodiazepines, antiepileptic, analgesics, pre-
gabalin, or cholinesterase inhibitor). One hundred forty-nine
patients and 50 controls underwent neuropsychological as-
sessment, while advanced disease or death prevented assess-
ment of the remaining patients.
One hundred participants underwent diﬀusion-weighted
MRI. After quality control (excluding 1 patient and 2 con-
trols), our imaging subset comprised 69 patients (22 PSP, 14
bvFTD, 14 CBS, 11 nvPPA, 4 svPPA, 4 other PPA) and 28
controls. To approximate group sizes, we evaluated PPA cases
as a group. The scanned patients did not diﬀer signiﬁcantly
from the nonscanned patients (table e-1, links.lww.com/
WNL/A261).
Cognitive and behavioral assessments
The test battery examined the major components of apathy
and impulsivity (table 1). Questionnaires sought multiple
perspectives, including clinician, patient, and carer. Com-
puterized behavioral tasks included measures of response in-
hibition (restraint: Go/NoGo, and cancellation: stop signal
task), reﬂection impulsivity (information sampling task), and
reward sensitivity (cued reinforcement reaction time task,
Cambridge Gambling Task). Saccade and motor versions of
the Go/NoGo task were used in view of the motor impair-
ment inherent to some FTLD syndromes. We also assessed
potential confounds including depression (Beck Depression
Inventory–II), anhedonia (Snaith-Hamilton Pleasure Scale),
Glossary
AES = Apathy Evaluation Scale; bvFTD = behavioral variant frontotemporal dementia;CBI =Cambridge Behavioral Inventory;
CBS = corticobasal syndrome; DTI = diﬀusion tensor imaging; FA = fractional anisotropy; FTD = frontotemporal dementia;
FTLD = frontotemporal lobar degeneration; MD = mean diﬀusivity; NPI = Neuropsychiatric Inventory; nvPPA = nonﬂuent
agrammatic variant primary progressive aphasia; PCA = principal component analysis; PiPPIN = Pick’s Disease and Progressive
Supranuclear Palsy: Prevalence and Incidence; PPA = primary progressive aphasia; PSP = progressive supranuclear palsy;
svPPA = semantic variant primary progressive aphasia; TFCE = threshold-free cluster enhancement.
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Table 1 PiPPIN neuropsychological and behavioral assessment battery
Measurement Description Variables for final PCA
Questionnaires
AES 18 items assessing emotional, behavioral, and cognitive constructs of apathy.
All 3 available versions (patient, carer, clinician) were used.
AES 1: Patient ratings
AES 2: Carer and clinician
BIS 30-item self-report questionnaire reflecting the multifactorial structure of
impulsivity. Outcome variables include attention, motor, self-control, cognitive
complexity, perseverance, and cognitive instability subscores.
BIS 1: Attention, self-control, cognitive
complexity, perseverance
BIS 2: Motor, cognitive instability
BIS/BAS 24-item self-report questionnaire based on Gray’s biopsychological theory of
personality. Outcome variables include the BIS subscore, reflecting aversive
behaviors, and the BAS drive, fun-seeking and reward responsiveness subscores,
reflecting appetitive behaviors.
BIS/BAS 1: BAS subscores
BIS/BAS 2: BIS subscore
MEI 27-item self-rated questionnaire developed to evaluate reductions in motivation
and energy in depression research, although frequently used in other disease
areas. The total score is the major outcome variable.
Total score
SHAPS 14-item self-rated questionnaire targeting hedonic capacity (anhedonia). The total
score is the major outcome variable.
Total score
BDI-II 21-item self-rated depression questionnaire. The total score is the major outcome
variable. The latest version, BDI-II, is designed for individuals aged 13 years and
older. Cutoff scores are well established: 0–9: minimal depression; 10–18: mild
depression; 19–29: moderate depression; and 30–63: severe depression.
Total score
CBI-R 45-item carer-rated questionnaire developed to evaluate behavioral changes
associated with dementia. Outcome variables include memory/orientation,
everyday skills, self-care, abnormal behavior, mood, beliefs, eating habits, sleep,
stereotypical behavior, and motivation subscores.
CBI 1: Challenging behaviors
CBI 2: Everyday skills and self-care
NPI 12-item carer-rated questionnaire assessing the severity and distress caused by
various behavioral disturbances. For the purposes of this study, only the apathy
and disinhibition subscores were used.
NPI apathy/disinhibition subscores
Kirby Serial forced-choice questionnaire to quantify the tendency to prefer small
immediate rewards over larger delayed rewards. Outcome variables included the
difference in K value, calculated as the difference in delayed discounting (K) from
small to large delayed rewards (Klarge − Ksmall), and termed Kdiff.
Kdiff single score (note no difference to
component structure if using standardized
outcome measures [K]).
Behavioral
tasks
CANTAB IST Reflection impulsivity task administered on a touch-screen computer. Participants
were presented with a 5 × 5 matrix of 25 gray boxes that, when selected, turned
blue/yellow. On fixed trials (5), participants were instructed to open as many boxes
as they liked, before deciding whether there were mostly blue or yellow boxes. On
decreasing trials (5), every selected box subtracted 10 points from a starting 250, to
encourage faster decision-making. Correct responses = 100 points; incorrect = −100
points. Outcome measures: probability of being correct, mean box-opening latency,
mean color-decision latency, mean boxes opened per trial, sampling errors,
discrimination errors, and total correct decisions.
IST 1: Proportion of correct trials, boxes
opened, total correct
IST 2: Box and color latency
IST 3: Sampling error, boxes opened
CRRT Reward sensitivity task measuring “reinforcement-related speeding,” administered
on a laptop and 3-button press pad. Before each trial, participants observed
a colored rectangle signaling the probability of reward following a correct
response (20% vs 80% probability). Participants then identified the “odd-one-out”
of 3 circles to receive feedback: 100 points for a fast correct, 1 point for a slow
correct response, and 0 points for an incorrect response. Forty practice trials
without feedback were used to titrate reaction time thresholds to individual
differences in cognitive speed. Outcomes: speeding, total errors.
CRRT 1: Difference speeding, speeding FH,
errors
CRRT 2: Difference speeding, speeding SH
Continued
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and akinesia (PSP Rating Scale and reaction times), as dis-
cussed in Lansdall et al.3
SPSS version 22.0 (IBM Corp., Armonk, NY) was used for
behavioral and neuropsychological analysis. Two-sample t
tests, corrected for multiple comparisons, were used for
group comparisons. Principal component analysis (PCA)
identiﬁed the major components of apathy and impulsiv-
ity.3 In brief, PCAs were run on control and patient data
combined (n = 199; noting no major diﬀerence to the
component structure using patient data only) with varimax
rotation and mean replacement for missing data. The cor-
relation matrix was used for component extraction based
on Kaiser and Cattell criteria (whichever was more in-
clusive), while Kaiser-Meyer-Olkin and Bartlett test of
sphericity conﬁrmed the adequacy of the sample for PCA.
Where questionnaires or tasks had multiple outcome
measures, we ﬁrst ran a “local PCA.” A “ﬁnal PCA” included
the lead component loadings from local PCAs and total
scores, accuracy (d-prime [d9]), or relevant subscores.
Component scores were compared across groups using
analysis of variance with post hoc least signiﬁcant diﬀerence
correction, and correlated with disease severity measures
using Pearson correlations.
Magnetic resonance imaging
Diﬀusion-weighted images were acquired using a Siemens
Magnetom Tim Trio (Siemens, Erlangen, Germany) with
a 63-direction gradient sequence with: b value 1,000 s/mm2;
repetition time 7,800milliseconds; echo time 90milliseconds;
axial in-plane acquisition matrix 96 × 96; ﬁeld of view 192 ×
192 mm; slice thickness 2 mm; and a total of 63 contiguous
slices with in-plane resolution 2-mm isotropic. An additional
b value of 0 s/mm2 image was acquired.
Images were processed using FMRIB Software Library (FSL
version 5.0; www.fmrib.ox.ac.uk/fsl), correcting for eddy
currents and participant motion by aﬃne registration to the
ﬁrst b0 image (FSL eddy_correct); bvecs were rotated
(fdt_rotate_bvecs). The b0 image was extracted and a brain
mask created (Brain Extraction Tool). Diﬀusion tensors were
ﬁtted (dtiﬁt) to create maps of fractional anisotropy (FA) and
mean diﬀusivity (MD). FA maps from 5 participants from
each group were nonlinearly registered to the
Table 1 PiPPIN neuropsychological and behavioral assessment battery (continued)
Measurement Description Variables for final PCA
CANTAB SST A response inhibition task (action cancellation), administered on a touch screen and
2-button press pad. Stimuli were presented on a computer screen and participants
were instructed to press the right/left button as quickly as possible in response to
the right/left arrow. For the test trials (64), participants were instructed to refrain
from responding when they heard an auditory signal (beep), presented in 25% of
trials (randomly dispersed). The delay between presentation of the arrow stimuli
and the stop signal (stop signal delay) varied, in order to estimate the stop signal
reaction time (time taken to successfully inhibit a response). The major outcome
variables included SSD, SSRT, total correct responses, direction errors, and mean/
median reaction times for all Go trials.
SST 1: SSRT, correct responses (proportion of
successful stops), median reaction time on
Go trials
Saccade
NoGo
The saccadic NoGo task used direct infrared oculography from a head-mounted
saccadometer (Ober Consulting Poland). Each session included 300 trials, following
10 calibration trials. Participants fixated centrally (red/green dots) on a screen at
approximately 1.5-m distance. After 300 milliseconds, one of the central cues was
removed and a red dot was presented at −10° or +10° horizontal displacement
(randomized, 50:50). In 50% of trials, the green central cue remained and
participants responded by a saccade to lateral target (Go trials). In NoGo trials,
the red central cue remained and participants refrained from making a saccade.
Outcome variables: calculated d9.
d9
Motor NoGo The motor NoGo task was analogous to the saccadic task but used a joystick
operated by the right hand (see supplementary material for details). Outcome
measures for NoGo tasks included d9 for performance accuracy, commission
and omission error rates, and reaction times. Calculated d9: Lower values
reflect decreased “hits” (correct on Go trials) and increased false alarms (Go on
NoGo trials: commission errors).
d9
CGT CANTAB Participants were presented with a row of red and blue boxes and were instructed
to guess which color box a yellow token was placed under, responding by touching
the boxes containing the words “red” or “blue.” In the gambling stages, participants
started with 250 points and could select their decision confidence by gambling
a certain proportion of these points, which were displayed in either ascending
(part 1) or descending (part 2) order. Participants were instructed to obtain as
many points as possible, and the total accumulated points were displayed on the
screen throughout. The gambling task was removed after 37 patients because of
difficult task engagement, even following simplification of the task.
NA
Abbreviations: AES = Apathy Evaluation Scale; BAS = Behavioral Activation System; BDI-II = Beck Depression Inventory–II; BIS = Barratt Impulsiveness Scale;
CANTAB = Cambridge Neuropsychological Test Automated Battery; CBI = Cambridge Behavioral Inventory; CBI-R = CBI-Revised; CGT = Cambridge Gambling
Task; CRRT = cued reinforcement reaction time; FH = first half of trials; d9 = d-prime; IST = information sampling task; MEI = Motivation and Energy Inventory;
NA = not applicable; NPI = Neuropsychiatric Inventory; PCA = principal component analysis; PiPPIN = Pick’s Disease and Progressive Supranuclear Palsy; SH =
second half of trials; SHAPS = Snaith-Hamilton Pleasure Scale; SSD = stop signal delay; SSRT = stop signal reaction time; SST = stop signal task.
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FMRIB58_FA_1 mm target (tbss_2_reg). The warped FA
images were averaged to produce a study-speciﬁc FA tem-
plate.17 Registration was repeated for all participants using
this study-speciﬁc FA template as target, bringing all partic-
ipants into the same anatomical space. From the study-
speciﬁc template, a mean FA skeleton was produced, and
individual FA skeletons were mapped to it (threshold = 0.2).
The transformations putting the individual FA maps into the
skeletonized standard space were applied to MD maps.
Tract-based spatial statistics were used to examine the rela-
tionships between changes in diﬀusion metrics and behav-
ior.18 Correlations between the skeleton DTI tracts and
components of apathy and impulsivity were assessed by
nonparametric permutation analysis using FSL randomise
with threshold-free cluster enhancement (TFCE) correction,
2-dimensional optimization, and 5,000 permutations. The
design matrix contained a constant term to model the in-
tercept and each of the 8 orthogonal principal components of
behavior. Cluster signiﬁcance was tested at p < 0.01 and p <
0.05, corrected for multiple comparisons. White matter was
labeled using the JHU (Johns Hopkins University) white-
matter tractography atlas and ICBM-DTI-81 (International
Consortium of Brain Mapping) white-matter labels atlas.
Results
Neuropsychological and behavioral results
Demographic, cognitive, neuropsychological, and behavioral
results of patients and control participants who underwent
DTI are displayed in table 2. Groups were matched for age
and sex, while patients were impaired in cognition, disease
severity, and most measures of apathy and impulsivity.
The PCA identiﬁed 8 components (table 3; table e-2, links.
lww.com/WNL/A261).3 Short summary terms were assigned
to each according to their major loadings, after Lansdall et al.3
Component 1, termed “patient-rated change,” reﬂected self-
ratings of apathy (Apathy Evaluation Scale [AES]), impul-
sivity (Barratt Impulsiveness Scale), anhedonia (Snaith-
Hamilton Pleasure Scale), depression (Beck Depression
Inventory–II), and motivation (Motivation and Energy In-
ventory). Components 2 and 3 were carer-based, weighted
toward the AES, Cambridge Behavioral Inventory (CBI), and
Neuropsychiatric Inventory (NPI); component 2, “carer-
rated change in everyday skills/self-care,” reﬂected apathy
(NPI apathy and AES), everyday skills, self-care, sleep, and
motivation (CBI), while component 3, “carer-rated change in
complex behaviors,” reﬂected apathy (AES), impulsivity (NPI
disinhibition), and stereotypic/complex behaviors (CBI).
Performance on the Go/NoGo, information sampling, and
cued reinforcement tasks loaded onto component 4, termed
“impulsive behavior.” Kaiser-Meyer-Olkin statistic = 0.743
and Bartlett test231 = 508; p < 0.001 conﬁrmed data suitability
for PCA. Patient-rated questionnaires, carer-rated ques-
tionnaires, and objective behavioral measures loaded onto
distinct components, including positive weighting of both
apathy and impulsivity measures.
Apathy and impulsivity were observed across the spectrum of
clinical syndromes, reﬂecting their transdiagnostic nature.
Signiﬁcant diﬀerences between diagnostic groups were ob-
served for loadings on components 1–4 (ﬁgure 1).
Diffusion tensor imaging
Tract-based spatial statistics identiﬁed signiﬁcant (TFCE-
corrected p < 0.01) changes in white matter in relation to
carer-rated change in everyday skills and self-care (compo-
nent 2, yellow-red) and carer-rated change in complex
behaviors (component 3, blue-green; p < 0.01) (ﬁgure 2).
Changes in MD and FA were complementary and highlighted
concordant patterns of white matter change in relation to
carer-rated change in everyday skills and self-care (compo-
nent 2) and carer-rated change in complex behaviors (com-
ponent 3). Loss of everyday skills correlated with FA
(negative) and MD (positive) in the genu, body, and sple-
nium of the corpus callosum, anterior and posterior corona
radiata, corticospinal tracts, and posterior thalamic radiation
(table e-3, links.lww.com/WNL/A261; ﬁgures e-1–e-3, links.
lww.com/WNL/A260). Complex behaviors, including im-
pulsivity, correlated with FA (negative) and MD (positive) in
frontotemporal connections between the orbital- and
ventrolateral-prefrontal cortex, anterior cingulate, and temporal
pole, including the genu and body of the corpus callosum,
anterior limb of the internal capsule, anterior thalamic radia-
tion, and anterior corona radiata (ﬁgures e-4 and e-5). The
anterior–posterior dissociation between components 3 and 2 is
most apparent for MD (ﬁgure 2A). The longitudinal, fronto-
occipital and uncinate fasciculi, and the forceps major and minor
were associated with both carer-rated components, with a more
restricted (anterior) distribution in relation to complex behaviors
(ﬁgures 2, e-4, and e-5). At the more liberal threshold of p < 0.05
(TFCE-corrected), component 4 correlated with MD changes
in regions connecting the presupplementary motor area and
dorsolateral prefrontal cortex, and occipital lobe (thalamic radi-
ation, forceps major, inferior fronto-occipital fasciculus, and in-
ferior longitudinal fasciculus; ﬁgures e-1 and e-6).
Discussion
Distinct spatial distributions of white matter pathology are re-
lated to separate dimensions of apathy and impulsivity, across
multiple syndromes associated with FTLD. Carers’ ratings of
complex and challenging behaviors (including apathy and im-
pulsivity, component 3) were associated with anterior changes in
the white matter tracts connecting ventrolateral and orbito-
frontal cortex and temporal poles. In contrast, carers’ ratings of
everyday skills, self-care, and apathy correlated with changes in
frontal, parietal, and corticospinal tracts. Our data also show that
(1) apathy and impulsivity are positively correlated, and (2) they
are present in all syndromes associated with FTLD. These crit-
ical results reinforce the phenotypic overlap between disorders,
reﬂected in new diagnostic terms such as PSP-CBS, PSP-F
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Table 2 Demographics and neuropsychiatric and behavioral results for imaged patients and controls
Variable
Imaged
controls
Imaged
patients
t Test,
p value PSP CBS PPA bvFTD
Demographics and cognition/
function
No. 28 69 NA 22 14 19 14
Age, y 68.4 ± 6.0 68.7 ± 8.0 NS 71.4 ± 7.4 66.9 ± 8.0 71.2 ± 7.5 63.9 ± 7.4
Sex, M/F 15/13 38/31 NS 12/10 7/7 11/8 8/6
ACE-R total (/100) 96.8 ± 3.2 67.3 ± 22.3 —a 78.6 ± 11.8 66.1 ± 25.3 53.4 ± 21.9 67.2 ± 25.1
MMSE total (/30) 29.5 ± 1.0 23.0 ± 6.8 —a 25.9 ± 4.3 21.7 ± 8.2 19.8 ± 7.3 23.5 ± 6.7
FRS % score (/100) 95.0 ± 6.8 40.6 ± 27.3 —a 44.4 ± 29.2 34.5 ± 25.7 51.5 ± 29.7 26.0 ± 12.3
PSP-RS NA 29.9 ± 18.6 —a 40.0 ± 11.4 37.3 ± 19.0 7.3 ± 5.4 16.0 ± 10.5
FAB 17.2 ± 0.9 10.5 ± 4.2 —a 11.4 ± 3.4 10.8 ± 4.8 8.9 ± 3.8 10.9 ± 5.1
Questionnaires
AES (/72)
Carerb 24.3 ± 5.4 46.9 ± 12.4 —a 47.2 ± 11.1 47.4 ± 10.7 41.2 ± 14.9 53.6 ± 9.4
Patientc 24.5 ± 5.2 36.7 ± 9.2 —a 39.7 ± 10.9 35.2 ± 5.7 37.6 ± 6.3 32.6 ± 10.2
Clinicianc 25.4 ± 7.6 43.4 ± 9.6 —a 46.6 ± 10.8 42.4 ± 8.4 38.8 ± 10.0 43.4 ± 6.7
BIS (/120) 57.1 ± 7.8 64.2 ± 7.8 —a 65.4 ± 7.7 61.1 ± 10.5 65.4 ± 7.0 63.7 ± 6.3
BIS/BASc
BIS subscore 20.3 ± 3.0 20.8 ± 4.7 NS 19.9 ± 3.3 21.9 ± 3.0 22.4 ± 7.6 19.7 ± 3.3
BAS drive 10.5 ± 1.6 11.0 ± 3.3 NS 11.1 ± 3.1 9.5 ± 3.2 10.6 ± 3.2 12.7 ± 3.4
BAS fun-seeking 10.9 ± 2.1 11.2 ± 2.9 NS 10.7 ± 2.8 9.5 ± 3.1 11.8 ± 2.3 13.0 ± 2.6
BAS reward responsiveness 15.7 ± 2.8 16.4 ± 2.7 NS 16.1 ± 2.9 16.6 ± 2.2 16.4 ± 2.3 16.9 ± 3.2
MEI (/144)d 112.8 ± 15.8 80.3 ± 27.4 —a 67.5 ± 30.4 76.9 ± 25.6 86.7 ± 14.6 97.3 ± 24.9
BDI (/63)c 3.6 ± 4.1 13.3 ± 10.7 —a 19.0 ± 12.5 12.6 ± 8.2 9.0 ± 10.0 9.2 ± 6.0
SHAPS (/56)d 18.7 ± 4.8 22.4 ± 5.1 —e 22.4 ± 4.7 23.1 ± 5.7 20.6 ± 3.8 23.5 ± 6.3
NPI, fraction with positive
responseb
Apathy subscore 0.00 ± 0.00 0.60 ± 0.49 —a 0.60 ± 0.50 0.71 ± 0.47 0.42 ± 0.51 0.71 ± 0.47
Disinhibition subscore 0.04 ± 0.19 0.36 ± 0.48 —a 0.29 ± 0.46 0.14 ± 0.36 0.32 ± 0.51 0.77 ± 0.44
CBI-R (/180)b 4.5 ± 4.2 62.8 ± 35.2 —a 50.9 ± 33.9 69.8 ± 36.1 53.3 ± 37.8 85.2 ± 20.4
Kirby (difference)d 0.01 ± 0.02 0.01 ± 0.05 NS 0.03 ± 0.04 0.02 ± 0.05 0.01 ± 0.03 −0.001 ±
0.08
Behavioral tasks
ISTd
Probability of being correct, fixed 0.78 ± 0.10 0.75 ± 0.15 —e 0.68 ± 0.15 0.59 ± 0.24 0.64 ± 0.11 0.73 ± 0.19
Probability of being correct,
decreasing
0.85 ± 0.12 0.67 ± 0.17 —e 0.75 ± 0.15 0.72 ± 0.14 0.68 ± 0.12 0.83 ± 0.14
CRRTd
Total errors 3.1 ± 2.9 4.2 ± 5.0 NS 3.7 ± 3.3 5.2 ± 5.0 7.0 ± 9.4 2.6 ± 2.1
Continued
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(frontal), and PSP-SL (speech/language).16 It also highlights the
advantages of a dimensional approach that accommodates
commonalties across groups and the convergence of syndromes
with disease progression. In doing so, we conﬁrm that even the
language variants, especially svPPA, cause signiﬁcant behavioral
change including apathy and impulsivity.2,3
The white matter abnormalities associated with challenging
behaviors (component 3: AES, NPI disinhibition, and CBI
abnormal/stereotypic behaviors, eating habits, andmotivation)
are consistent with previous studies linking apathy and im-
pulsivity to abnormal white matter and metabolism in fronto-
temporal regions.1,2,4 They mirror white matter tract
abnormalities in bvFTD,7,19 for which apathy and impulsivity
are diagnostic criteria. Moreover, the uncinate fasciculus is
linked to inhibitory control in bvFTD and apathy in Alzheimer
disease,17 small vessel disease,20 PSP,21 and bvFTD.1 This
suggests a common neural pathway, across disorders.
Carer-rated change in everyday skills, self-care, motivation, and
apathy correlated with widespread white matter changes in the
corpus callosum, corona radiata, superior longitudinal fasciculus,
and thalamic radiation. In contrast to carer-rated change in
complex behaviors, there was less emphasis on rostral fronto-
temporal change. PSP and CBS groups scored most highly on
this component, although all groups scored higher on average
than controls (ﬁgure 1). The results support previous volumetric
analyses showing the following: (1) PSP degeneration of the
brainstem and association and commissural ﬁbers including su-
perior cerebellar peduncles, corpus callosum, inferior longitudi-
nal fasciculus, and superior longitudinal fasciculus21; (2) CBS
changes in frontoparietal tracts and corpus callosum22; and (3)
FTD widespread changes.23
The widespread abnormalities are consistent with network-
based disruption in FTLD,24–26 aﬀecting broadly distributed
frontotemporal networks rather than focal areas of damage.
However, multifocal changes associated with carer reports may
also reﬂect an inability to diﬀerentiate behavioral proﬁles using
these questionnaires. Nonetheless, the tract-based statistics were
broadly consistent with volumetric3 evidence of the breakdown
of frontostriatal and frontotemporal circuits for motivation,3,5
coordinating the multiple cognitive domains necessary for
planning and executing eﬀective goal-directed behavior.27
One diﬀerence between the former volumetric study and cur-
rent DTI results is the absence of a tract-based deﬁcit in relation
to patients’ observations of their own symptomatology (table
3).3 There are several explanations for this discordance. First,
patient ratingsmay reﬂect heterogeneous, multifocal changes in
white matter, which prevent the identiﬁcation of consistently
localized tract correlates. Second, volumetric and DTI analyses
assess fundamentally distinct neuropathologic features (tissue
loss and T1 signal change vs the diﬀusional integrity of white
matter connections), leading to diﬀerent statistical associations.
For example, patient ratings may reﬂect volumetric changes in
deep white matter structures that are not captured by DTI.
Third, the diﬀerence may reﬂect the limitations of white matter
voxel-based morphometry,18 arising from normalization errors,
mislocalization, or the partial-volume eﬀects of smoothing,
which can give rise to false-positives. The current tract-based
method is less vulnerable to these issues, although there are
limitations to the interpretation of DTI, which are discussed
below. With the tract-based method, current white matter
changes appear more extensive than the previously reported
gray matter atrophy. For example, performance on the objec-
tive behavioral tasks correlated with white matter tract meas-
ures in the right frontal cortex, as well as white matter tracts
near the regions of posterior and subcortical atrophy.3 This
diﬀerence may be attributable to diﬀerential signal-to-noise of
the 2 methods but may also reﬂect the core white matter
pathophysiology in syndromes associated with FTLD.7
Table 2 Demographics and neuropsychiatric and behavioral results for imaged patients and controls (continued)
Variable
Imaged
controls
Imaged
patients
t Test,
p value PSP CBS PPA bvFTD
SSTd
SSRT 175.8 ± 42.8 447.0 ± 244.3 —a 449.4 ±
189.0
544.3 ±
430.7
471.8 ±
242.5
353.0 ±
152.2
Motor Go/NoGo d9d 4.5 ± 0.3 3.2 ± 1.3 —a 3.4 ± 1.0 2.9 ± 1.6 3.0 ± 1.4 3.6 ± 1.5
Saccade d9d 2.6 ± 0.9 0.8 ± 1.1 —a 0.7 ± 0.9 1.0 ± 0.8 0.5 ± 1.2 1.1 ± 1.4
Abbreviations: ACE-R = Addenbrooke’s Cognitive Examination–Revised; AES = Apathy Evaluation Scale; BAS = Behavioral Activation System; BDI = Beck
Depression Inventory; BIS = Barratt Impulsiveness Scale; bvFTD = behavioral variant frontotemporal dementia; CBI-R = Cambridge Behavioral Inventory–
Revised; CBS = corticobasal syndrome; CRRT = cued reinforcement reaction time; d9 = d-prime; FAB = frontal assessment battery; FRS = Frontotemporal
Dementia Rating Scale; IST = information sampling task; MEI =Motivation and Energy Inventory; MMSE =Mini-Mental State Examination; NA = not applicable;
NPI = Neuropsychiatric Inventory; NS = not significant; PPA = primary progressive aphasia; PSP = progressive supranuclear palsy; PSP-RS = PSP Rating Scale;
SHAPS = Snaith-Hamilton Pleasure Scale; SSRT = stop signal reaction time; SST = stop signal task.
Stats indicate Student t test results comparing imaged controls (n = 28) and patients (n = 67).
a p < 0.01 (survives Bonferroni correction for multiple comparisons).
b Up to 5 missing data points.
c Up to 10 missing data points.
d More than 10 missing data points.
e p < 0.05.
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Although the behavioral task performance showed weaker cor-
relations withMD and the carer ratings, its anatomical correlates
are of particular relevance. First, all patient groups performed
worse than controls (ﬁgure 1D), conﬁrming the objective neu-
ropsychological deﬁcits as a transdiagnostic phenomenon. Sec-
ond, these regions (presupplementary motor area, dorsolateral
prefrontal cortex, and inferior frontal gyrus; ﬁgure e-1, links.lww.
com/WNL/A260) and their interconnections are strongly as-
sociated with cognitive and motor control in preclinical models
and human studies.28–30 Reduced connectivity among these
regions aﬀects response inhibition31 and choices between alter-
nate actions.32,33
Carer ratings and behavioral task performance all correlated with
cognitive and functional decline. Previous studies have reported
a link between apathy and poor outcome,20 with rapid cognitive
and functional deterioration in apathetic patients compared to
nonapathetic and depressed individuals.34 Further investigations
assessing the prognostic implications of apathy and impulsivity in
FTLD syndromes are warranted.
There are limitations to this study and caveats to the methods.
DTI is an indirect measure of the physical properties of brain
parenchyma, including white matter axon density, caliber, and
myelination.35 The pathologic causes of abnormal diﬀusion are
not fully elucidated. Even though the semiquantitative in vivo
measures provide important anatomical insights, cross-validation
with neuropathology is sparse. For example, preclinical studies
link FA to myelination, membrane permeability, and ﬁber den-
sity in white matter.36 Comparative studies of anatomy across
species and in FTLD post mortem are required to determine the
pathologic mechanisms of the imaging changes we observe. Al-
though diﬀerent DTI metrics may reﬂect distinct processes
(demyelination, neurodegeneration, gliosis, calciﬁcation, axonal
degeneration, etc.), linking them to speciﬁc leucopathologies
remains challenging. One must also consider artifacts from
motion and registration errors, as multiple directional measure-
ments are obtained at each voxel, introducing false-positive dif-
ferences if movement diﬀers by group.37 Registration poses
signiﬁcant challenges for FTLD groups with highly atrophic
brains, obscuring some tracts and aﬀecting the absolute
Table 3 Components 1–4 extracted from principal component analysis
Input variable
Component structure
1: Patient-rated
change
2: Carer-rated change: Everyday
skills and self-care
3: Carer-rated change:
Challenging behaviors
4: Impulsive
behaviors
Initial eigenvalue 4.962 2.183 1.664 1.514
Rotated eigenvalue 3.438 2.284 2.145 1.819
AES 1 0.832a −0.069 −0.121 0.151
BIS 1 0.735a 0.086 0.083 0.221
BDI total score 0.756a 0.345 0.100 0.073
MEI total score −0.837a −0.232 −0.061 −0.109
SHAPS total score 0.688a 0.147 0.281 −0.067
AES 2 0.067 0.714a 0.529a 0.074
CBI 2 0.233 0.831a −0.084 0.151
NPI apathy subscore 0.192 0.705a 0.355 0.119
CBI 1 0.035 0.118 0.880a 0.078
NPI disinhibition subscore 0.135 0.083 0.825a −0.008
IST 2 0.170 0.030 −0.037 0.683a
CRRT 1 0.007 0.014 −0.006 0.658a
Go/NoGo d9 −0.259 −0.135 −0.113 −0.642a
Saccades d9 −0.162 −0.198 −0.081 −0.530a
Abbreviations: AES = Apathy Evaluation Scale; BDI = Beck Depression Inventory; BIS = Barratt Impulsiveness Scale; CBI = Cambridge Behavioral Inventory;
CRRT = cued reinforcement reaction time; d9 = d-prime; MEI = Motivation and Energy Inventory; NPI = Neuropsychiatric Inventory; SHAPS = Snaith-Hamilton
Pleasure Scale.
For the full set of 8 components, see table e-2 (http://links.lww.com/WNL/A261). Numerical values following the input variables reflect results from local
principal component analyses (table 1). Measures of both apathy (AES) and impulsivity (BIS) load positively onto the same components, such that increased
apathy also reflects increased impulsivity. Patient, carer, and objective measures each load onto distinct components, suggesting they measure different
aspects of disease. The lack of overlap between behavioral tasks and questionnaires is concerning and has direct implications for translational studies,
whereby behavioral tests in animal models are considered to capture behavioral changes assessed through questionnaires in clinical human studies. Go/
NoGo motor and saccade tasks both loaded onto the same component, in the same direction, suggesting that saccade analysis represents an appropriate
alternative for measuring impulse control in those with functional disability.
a variables with strong loadings onto each component (>0.5).
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Figure 1 Component scores by diagnostic group
(A–D) Boxplots of principal component scores (2–4) by diagnosis for the imaged subset (n = 97). Bars indicate significant differences between each group and
controls using analysis of variance with post hoc least significant difference tests (solid lines p < 0.001, dashed lines p < 0.05), and circles/stars represent
outliers (1.5*IQR/3*IQR, respectively). (A) Component 1 representing patient-rated behavioral change as measured by the AES, Barratt Impulsiveness Scale,
Snaith-Hamilton Pleasure Scale, Beck Depression Inventory–II, and Motivation and Energy Inventory. (B) Component 2 reflecting carer-rated change in
everyday skills, self-care, andmotivation asmeasured by the CBI subscores, AES, and NPI apathy subscore. (C) Component 3 reflecting carer-rated change in
complex behaviors as measured by the CBI abnormal/stereotypic behaviors, eating habits, mood and motivation subscores, AES, and NPI disinhibition
subscore. (D) Component 4 indicating poor performance on behavioral tasks of response inhibition (Go/NoGo motor and saccade), reflection impulsivity
(information sampling task), and reward responsiveness (cured reinforcement reaction time task). Significant differences were also observed between
groups for component 1 (F4,92 = 7.462, p < 0.001, post hoc control vs PSP p < 0.001, vs CBS p < 0.05, vs PPA p < 0.05, PSP vs PPA p < 0.05, vs bvFTD p < 0.05),
component 2 (F4,92 = 9.132, p < 0.001, post hoc control vs PSP p < 0.001, vs CBS p < 0.001, PSP vs CBS p < 0.05, vs PPA, p < 0.05, CBS vs PPA p < 0.001, vs bvFTD p =
0.001), component 3 (F4,92 = 23.832, p < 0.001, post hoc control vs bvFTD p < 0.001, vs PPA p < 0.05, PSP vs bvFTD p < 0.001, CBS vs bvFTD p < 0.001, PPA vs bvFTD
p < 0.001), component 4 (F4,92 = 10.902, p < 0.001, post hoc control vs PSP p = 0.001, CBS p < 0.05, PPA p < 0.001, bvFTD p < 0.05, PSP vs PPA p < 0.05, CBS vs PPA
p < 0.05, PPA vs bvFTD p = 0.001). (E) Components 1–4 correlatedwithmeasures of cognition (ACE-R,MMSE, FAB) anddisease severity (FRS, PSP-RS) with higher
component scores reflecting greater cognitive impairment, functional decline, and disease severity (note Pearson correlation, p < 0.001 uncorrected here
approximates p < 0.05 corrected for multiple comparisons). * = p < 0.05; ** = p < 0.001 unc; ACE-R = Addenbrooke’s Cognitive Examination–Revised; AES =
Apathy Evaluation Scale; bvFTD = behavioral variant frontotemporal dementia; CBI = Cambridge Behavioral Inventory; CBS = corticobasal syndrome; FAB =
frontal assessment battery; FRS = Frontotemporal Dementia Rating Scale; IQR = interquartile range; MMSE = Mini-Mental State Examination; NPI = Neuro-
psychiatric Inventory; PPA = primary progressive aphasia (all groups); PSP = progressive supranuclear palsy; PSP-RS = PSP Rating Scale.
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diﬀusivities or eigenvalues.38 White matter change in areas with
substantial gray matter atrophymay lead to changes in estimated
FA/MD that reﬂect diﬀerences in the relative amounts of tissue
types rather than change in white matter.18 In addition to these
general DTI considerations, tract-based spatial statistics also has
caveats. It attempts to overcome misregistration issues and en-
sure the same region (or voxel) corresponds across groups by
creating a mean FA skeleton, onto which each individual’s FA is
projected prior to statistics. This relies on accurate coregistration
of FA images.White matter lesions that reduce FAmay also alter
the values chosen to represent the core of the tract during FA
projection.39 Despite these risks, we favor tract-based spatial
statistics over other frequently used whole-brain methods be-
cause of its increased sensitivity40 and power.39
A neuropsychological battery is necessarily selective, and our
ﬁndings are limited to the patients studied and the dimensions
of apathy and impulsivity accessible to our tests and ques-
tionnaires. PiPPIN aimed to assess the multifaceted constructs
of apathy and impulsivity, while accommodating the frailty of
patients. Nonetheless, many patients found the Cambridge
Gambling Task diﬃcult to perform adequately. However,
pathologic gambling is uncommon in FTLD disorders, and
including this task in a subsidiary PCA did not alter the factor
structure. Alternative tasks and questionnaires (e.g., cued re-
inforcement reaction time) remained, to assess motivation and
reward. We acknowledge that questionnaires are limited in
their ability to determine the underlying cause of behavioral
change. For example, answering “he/she shows less enthusiasm
for his or her usual interests” may be confounded by learned
restrictions arising from physical motor impairments, or be
inﬂuenced by semantic impairments and executive deﬁcits. By
using many tasks across a number of populations, we suggest
that the extracted dimensions of apathy and impulsivity more
accurately capture the essence of these behavioral changes than
the use of single questions or tasks in isolation.
Finally, although PiPPIN aimed to be representative of the full
population of aﬀected patients, somemay not have a diagnosis or
be in contact with referring services. We also rely on clinical
Figure 2 White matter changes associated with carer-rated everyday skills (component 2) and carer-rated complex
behaviors (component 3)
Whitematter correlates of carer-rated change in everyday skills and self-care (component 2: yellow-red) and carer-rated change in complex behaviors (component 3:
blue-green), asmeasuredby tract-basedspatial statisticsofdiffusion tensor imaging.Correlationsbetween theskeletonizeddiffusion tensor imaging–based tractsand
the components were assessed by nonparametric permutation analysis using FSL randomise with threshold-free cluster enhancement correction, 2-dimensional
optimization, and 5,000 permutations. Cluster significance was tested at p < 0.01 and corrected for multiple comparisons.
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diagnostic criteria and acknowledge that some variants (svPPA,
PSP) have much stronger clinic–pathologic correlations than
others (CBS, bvFTD). Although we used multiple sources of
referral in community and specialist services to reach all patients
within the catchment area, some may have been missed.
Nonetheless, the imaging subset was similar to the whole cohort.
White matter is markedly abnormal in the clinical syndromes
associated with FTLD. DTI was sensitive to the white matter
changes underlying FTLD-associated behaviors and revealed
distinct spatial proﬁles relating to diﬀerent aspects of apathy
and impulsivity. These complex, multifaceted constructs are
common across the FTLD spectrum and remain poorly
treated. Elucidating the neural correlates of apathy and im-
pulsivity, transdiagnostically, will help to inform the design of
clinical trials for novel therapeutic strategies.
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